FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) is an insurtech company that completed its de-SPAC merger with CF Acquisition Corp. VIII, a blank-check vehicle sponsored by Cantor Fitzgerald, in September 2022. The company operates in the life insurance technology sector, applying epigenetic biomarker science to modernize life insurance underwriting and distribution. FOXO has remained a reporting public company and filed an 8-K with the SEC on August 14, 2026 (accession 0001493152-26-038356), continuing its disclosure obligations under exchange rules. The company has navigated a challenging post-merger operating environment common to many small-cap insurtech issuers. For complete filing history, capital structure data, and real-time SPAC analytics on FOXO and hundreds of other transactions, sign up for full access at SpacDesk.